
Bahar Alawi Craigo
Examiner (ID: 2811, Phone: (571)270-1326 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1759, 1673, 1699, 1623, 4131 |
| Total Applications | 904 |
| Issued Applications | 359 |
| Pending Applications | 130 |
| Abandoned Applications | 452 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8016373
[patent_doc_number] => 08137685
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-20
[patent_title] => 'Hyaluronic acid compound, hydrogel thereof and joint treating material'
[patent_app_type] => utility
[patent_app_number] => 10/577154
[patent_app_country] => US
[patent_app_date] => 2004-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4043
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/137/08137685.pdf
[firstpage_image] =>[orig_patent_app_number] => 10577154
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/577154 | Hyaluronic acid compound, hydrogel thereof and joint treating material | Oct 26, 2004 | Issued |
Array
(
[id] => 5247395
[patent_doc_number] => 20070243629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-18
[patent_title] => 'High Affinity Ligands for Influenza Virus and Methods for Their Production'
[patent_app_type] => utility
[patent_app_number] => 10/576477
[patent_app_country] => US
[patent_app_date] => 2004-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 77
[patent_figures_cnt] => 77
[patent_no_of_words] => 15485
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0243/20070243629.pdf
[firstpage_image] =>[orig_patent_app_number] => 10576477
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/576477 | High Affinity Ligands for Influenza Virus and Methods for Their Production | Oct 19, 2004 | Abandoned |
Array
(
[id] => 5392171
[patent_doc_number] => 20090209484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'PREVENTIVE AND/OR THERAPEUTIC AGENT FOR CALCIPENIA'
[patent_app_type] => utility
[patent_app_number] => 11/573458
[patent_app_country] => US
[patent_app_date] => 2004-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10258
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20090209484.pdf
[firstpage_image] =>[orig_patent_app_number] => 11573458
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/573458 | Preventive and/or therapeutic agent for calcipenia | Aug 12, 2004 | Issued |
Array
(
[id] => 5648685
[patent_doc_number] => 20060134417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Molded object comprising alpha-1,4-glucans and/or modifications thereof and process for producing the same'
[patent_app_type] => utility
[patent_app_number] => 10/563595
[patent_app_country] => US
[patent_app_date] => 2004-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12380
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20060134417.pdf
[firstpage_image] =>[orig_patent_app_number] => 10563595
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/563595 | Molded object comprising α-1,4-glucans and/or modifications thereof and process for producing the same | Jul 8, 2004 | Issued |
Array
(
[id] => 5297087
[patent_doc_number] => 20090012013
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2009-01-08
[patent_title] => 'Steroid modified solatrioses'
[patent_app_type] => utility
[patent_app_number] => 10/563745
[patent_app_country] => US
[patent_app_date] => 2004-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2731
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0012/20090012013.pdf
[firstpage_image] =>[orig_patent_app_number] => 10563745
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/563745 | Steroid modified solatrioses | Jul 7, 2004 | Abandoned |
Array
(
[id] => 5297087
[patent_doc_number] => 20090012013
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2009-01-08
[patent_title] => 'Steroid modified solatrioses'
[patent_app_type] => utility
[patent_app_number] => 10/563745
[patent_app_country] => US
[patent_app_date] => 2004-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2731
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0012/20090012013.pdf
[firstpage_image] =>[orig_patent_app_number] => 10563745
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/563745 | Steroid modified solatrioses | Jul 7, 2004 | Abandoned |
Array
(
[id] => 4840352
[patent_doc_number] => 20080280838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-13
[patent_title] => 'Composition Containing Ginsenoside F1 and Egcg for Preventing Skin Damage'
[patent_app_type] => utility
[patent_app_number] => 10/599290
[patent_app_country] => US
[patent_app_date] => 2004-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5408
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20080280838.pdf
[firstpage_image] =>[orig_patent_app_number] => 10599290
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/599290 | Composition Containing Ginsenoside F1 and Egcg for Preventing Skin Damage | May 31, 2004 | Abandoned |
Array
(
[id] => 5464313
[patent_doc_number] => 20090324513
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'Process for Producing Chlorinated Sucrose'
[patent_app_type] => utility
[patent_app_number] => 10/593158
[patent_app_country] => US
[patent_app_date] => 2004-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6009
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0324/20090324513.pdf
[firstpage_image] =>[orig_patent_app_number] => 10593158
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/593158 | Process for Producing Chlorinated Sucrose | May 19, 2004 | Abandoned |
Array
(
[id] => 5540001
[patent_doc_number] => 20090221806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'Method for Producing a Beta-1,3-Glucan With Improved Characteristics'
[patent_app_type] => utility
[patent_app_number] => 10/544820
[patent_app_country] => US
[patent_app_date] => 2004-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3812
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20090221806.pdf
[firstpage_image] =>[orig_patent_app_number] => 10544820
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/544820 | Method for Producing a Beta-1,3-Glucan With Improved Characteristics | Mar 3, 2004 | Abandoned |
Array
(
[id] => 5694746
[patent_doc_number] => 20060154893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-13
[patent_title] => 'Exopolysaccharides delivery system for active molecules'
[patent_app_type] => utility
[patent_app_number] => 10/537118
[patent_app_country] => US
[patent_app_date] => 2003-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6368
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20060154893.pdf
[firstpage_image] =>[orig_patent_app_number] => 10537118
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/537118 | Exopolysaccharides delivery system for active molecules | Dec 3, 2003 | Issued |